DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,439,972 | -3.9% | 5,804 | -7.0% | 0.47% | +2.2% |
| Q2 2023 | $1,498,560 | -5.7% | 6,244 | -1.0% | 0.46% | -9.2% |
| Q1 2023 | $1,588,860 | -5.4% | 6,304 | -0.4% | 0.51% | -8.3% |
| Q4 2022 | $1,679,843 | +1.9% | 6,329 | -0.8% | 0.56% | +115.5% |
| Q3 2022 | $1,648,000 | +1.9% | 6,382 | 0.0% | 0.26% | -53.3% |
| Q2 2022 | $1,618,000 | -14.4% | 6,382 | -1.0% | 0.55% | +52.1% |
| Q1 2022 | $1,891,000 | -12.2% | 6,447 | -1.5% | 0.36% | -44.4% |
| Q4 2021 | $2,153,000 | +7.9% | 6,545 | -0.1% | 0.65% | +13.4% |
| Q3 2021 | $1,995,000 | +8.2% | 6,554 | -4.5% | 0.58% | -7.2% |
| Q2 2021 | $1,843,000 | +17.5% | 6,866 | -1.5% | 0.62% | +9.3% |
| Q1 2021 | $1,568,000 | +1.8% | 6,968 | +0.4% | 0.57% | +129.0% |
| Q4 2020 | $1,541,000 | +2.7% | 6,938 | -0.4% | 0.25% | -60.4% |
| Q3 2020 | $1,500,000 | +12.7% | 6,968 | +5.8% | 0.63% | +9.0% |
| Q2 2020 | $1,331,000 | +41.0% | 6,587 | +6.6% | 0.58% | +16.4% |
| Q1 2020 | $944,000 | -4.9% | 6,182 | -4.4% | 0.49% | +366.0% |
| Q4 2019 | $993,000 | +6.3% | 6,468 | 0.0% | 0.11% | -75.9% |
| Q3 2019 | $934,000 | -5.8% | 6,468 | -6.7% | 0.44% | +1592.3% |
| Q2 2019 | $991,000 | +3.8% | 6,934 | -4.1% | 0.03% | -93.2% |
| Q1 2019 | $955,000 | +26.7% | 7,234 | -1.0% | 0.38% | +500.0% |
| Q4 2018 | $754,000 | +0.3% | 7,309 | +3.9% | 0.06% | -80.5% |
| Q3 2018 | $752,000 | +8.4% | 7,034 | 0.0% | 0.33% | +615.2% |
| Q2 2018 | $694,000 | -1.6% | 7,034 | -1.1% | 0.05% | -87.1% |
| Q1 2018 | $705,000 | +2.8% | 7,109 | -3.9% | 0.36% | +3.8% |
| Q4 2017 | $686,000 | +7.0% | 7,396 | -1.0% | 0.34% | +0.3% |
| Q3 2017 | $641,000 | +1.7% | 7,469 | 0.0% | 0.34% | -2.3% |
| Q2 2017 | $630,000 | -0.9% | 7,469 | +0.5% | 0.35% | +24.1% |
| Q1 2017 | $636,000 | +9.5% | 7,434 | -0.3% | 0.28% | -20.3% |
| Q4 2016 | $581,000 | -4.9% | 7,459 | -4.3% | 0.35% | -7.8% |
| Q3 2016 | $611,000 | -19.8% | 7,791 | +3.2% | 0.38% | -19.3% |
| Q2 2016 | $762,000 | +4.1% | 7,546 | -2.3% | 0.48% | -10.7% |
| Q1 2016 | $732,000 | -8.0% | 7,721 | -9.9% | 0.53% | -5.2% |
| Q4 2015 | $796,000 | +7.3% | 8,571 | -1.5% | 0.56% | +17.8% |
| Q3 2015 | $742,000 | -0.4% | 8,704 | 0.0% | 0.48% | -11.0% |
| Q2 2015 | $745,000 | -0.9% | 8,704 | -1.7% | 0.54% | -0.2% |
| Q1 2015 | $752,000 | -3.1% | 8,854 | -2.2% | 0.54% | +15.7% |
| Q4 2014 | $776,000 | +12.8% | 9,054 | 0.0% | 0.46% | -10.3% |
| Q3 2014 | $688,000 | -3.5% | 9,054 | 0.0% | 0.52% | +27.3% |
| Q2 2014 | $713,000 | +5.0% | 9,054 | 0.0% | 0.41% | -15.9% |
| Q1 2014 | $679,000 | -3.1% | 9,054 | -0.3% | 0.48% | +1320.6% |
| Q4 2013 | $701,000 | +15.1% | 9,084 | +3.4% | 0.03% | -92.8% |
| Q3 2013 | $609,000 | +9.5% | 8,786 | 0.0% | 0.47% | +1000.0% |
| Q2 2013 | $556,000 | – | 8,786 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |